Mercados españoles abiertos en 6 hrs 59 min

Fresenius Medical Care AG (0H9X.IL)

IOB - IOB Precio demorado. Divisa en EUR
Añadir a la lista de favoritos
40,40+0,15 (+0,38%)
Al cierre: 05:36PM BST

Fresenius Medical Care AG

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

Sector(es)Healthcare
SectorMedical Care Facilities
Empleados a tiempo completo124.295

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Ms. Helen GizaCEO & Chair of Management Board of Fresenius Med. Care Mgmt AG3,21MN/A1968
Dr. Franklin W. Maddux F.A.C.P.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG2,42MN/A1957
Mr. William J. ValleManagement Board Member for Care Delivery of Fresenius Medical Care Management AG3,93MN/A1960
Dr. Katarzyna Mazur-Hofsab Ph.D.Management Board Member for Care Enablement of Fresenius Medical Care Management AG2,35MN/A1963
Mr. Roberto FusteExec. Advisor for Regional StrategyN/AN/A1952
Mr. Martin FischerCFO & Member of the Management Board of Fresenius Medical Care Management AGN/AN/A1977
Dr. Dominik HegerExec. VP and Head of Investor Relations, Strategic Devel. & CommunicationsN/AN/AN/A
Mr. Borries Von MullerSr. VP of Global HR Employee CommunicationsN/AN/A1961
Mr. Joachim WeithSr. VP of Corp. Communications & Gov.al AffairsN/AN/AN/A
Mr. Oliver MaierSr. VP Investor RelationsN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Gobierno corporativo

El ISS Governance QualityScore de Fresenius Medical Care AG, a día 1 de octubre de 2023, es 8. Las puntuaciones base son Auditoría: 2; Tablero: 6; Derechos de los accionistas: 1; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.